IL214785A0 - Dihydrolipoic acid derivatives comprising nitric oxide and therapeutic uses thereof - Google Patents

Dihydrolipoic acid derivatives comprising nitric oxide and therapeutic uses thereof

Info

Publication number
IL214785A0
IL214785A0 IL214785A IL21478511A IL214785A0 IL 214785 A0 IL214785 A0 IL 214785A0 IL 214785 A IL214785 A IL 214785A IL 21478511 A IL21478511 A IL 21478511A IL 214785 A0 IL214785 A0 IL 214785A0
Authority
IL
Israel
Prior art keywords
acid derivatives
nitric oxide
therapeutic uses
dihydrolipoic acid
dihydrolipoic
Prior art date
Application number
IL214785A
Original Assignee
Invasc Therapeutics Inc
Parthasarathy Sampath
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2010/024772 external-priority patent/WO2010096677A2/en
Application filed by Invasc Therapeutics Inc, Parthasarathy Sampath filed Critical Invasc Therapeutics Inc
Publication of IL214785A0 publication Critical patent/IL214785A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C313/00Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C313/08Sulfenic acids; Derivatives thereof
    • C07C313/18Sulfenamides
    • C07C313/36Sulfenamides having nitrogen atoms of sulfenamide groups further bound to other hetero atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/64Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
IL214785A 2010-02-19 2011-08-22 Dihydrolipoic acid derivatives comprising nitric oxide and therapeutic uses thereof IL214785A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2010/024772 WO2010096677A2 (en) 2009-02-17 2010-02-19 Dihydrolipoic acid derivatives comprising nitric oxide and therapeutic uses thereof

Publications (1)

Publication Number Publication Date
IL214785A0 true IL214785A0 (en) 2011-11-30

Family

ID=45774361

Family Applications (1)

Application Number Title Priority Date Filing Date
IL214785A IL214785A0 (en) 2010-02-19 2011-08-22 Dihydrolipoic acid derivatives comprising nitric oxide and therapeutic uses thereof

Country Status (6)

Country Link
JP (1) JP2013507325A (en)
KR (1) KR20120107076A (en)
AU (1) AU2010215871A1 (en)
CA (1) CA2777743A1 (en)
IL (1) IL214785A0 (en)
RU (1) RU2012103757A (en)

Also Published As

Publication number Publication date
CA2777743A1 (en) 2010-08-26
KR20120107076A (en) 2012-09-28
JP2013507325A (en) 2013-03-04
RU2012103757A (en) 2013-12-20
AU2010215871A1 (en) 2012-11-15

Similar Documents

Publication Publication Date Title
HUS1900017I1 (en) Cyclic boronic acid ester derivatives and therapeutic uses thereof
IL250259A0 (en) Compositions comprising ursolic acid and derivatives thereof and uses thereof
HK1192879A1 (en) Substituted 1-benzylcycloalkylcarboxlic acids and use thereof 1-
HK1187049A1 (en) Bisaryl-bonded aryltriazolones and use thereof
HK1178538A1 (en) Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals - 3--
PL2605757T3 (en) Nalbuphine-based formulations and uses thereof
PT2521445T (en) Formulation and use thereof
IL236965B (en) Derivatives of 5-aminolevulinic acid and uses thereof
IL226003A0 (en) Trans-2-decenoic acid derivative and pharmaceutical agent containing the same
PT2563806E (en) Human leukolectins and uses thereof
EP2864345A4 (en) Particle-nucleic acid conjugates and therapeutic uses related thereto
PL2648715T3 (en) Carnosine-hyaluronic acid mixtures and their use
EP2542967A4 (en) High and low value application state
HK1184779A1 (en) Novel compound and medical use thereof
EP2539317A4 (en) Dihydrolipoic acid derivatives comprising nitric oxide and therapeutic uses thereof
HK1162526A1 (en) Glp-1 derivatives and uses thereof glp-1
IL214785A0 (en) Dihydrolipoic acid derivatives comprising nitric oxide and therapeutic uses thereof
GB201012660D0 (en) Inhaler and formulation
EP2657236A4 (en) Novel 2-alkynyl-n9-propargyladenine and medicinal use thereof
GB201005712D0 (en) Medicaments and their manufacture